Hematology is a branch of science dealing with diagnosis, treatment, and study of blood, blood components, and disorders related to blood such as blood malignant growth, frailty, hemophilia, and blood clumps. Hematological tests include in vitro diagnostic tests which include hemostasis, histology, molecular diagnostics, blood examination, and flow cytometry and help to recognize different blood-related diseases. Hematology includes issues related to red blood cells (RBC’s), white blood cells (WBC’s), platelets and organs that are nourished by blood cells, including the spleen, thymus, lymph nodes, and lymphoid tissue.
Key players are focusing on adoption of inorganic strategies such as mergers and acquisitions in order to expand their product portfolio and geographical presence in the global hematology market. For instance, in September 2019, CellaVision AB, a global medical technology company that develops and sells leading systems for routine analysis of blood and other body fluids in health care services, has acquired RAL Diagnostics, a leading producer and market actor in reagents in hematology, bacteriology, parasitology, cytology and pathology. This acquisition gives CellaVision a well-established brand with solutions in staining and sample preparation of the highest quality. CellaVision and RAL together created an increased customer value in digital morphology by offering a complete and integrated solution for the hematology laboratory.
- This report provides in-depth analysis of the global hematology market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global hematology market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Abbott Laboratories, Sysmex Co., Beckman Coulter, Horiba, Ltd., Boule Diagnostics AB, Mind ray Medical International Limited, Siemens Healthcare, Roche Diagnostics, Bio Rad laboratories, Sigma Aldrich Co., and Nihon Kohden Corporation.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global hematology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hematology market
-
- Hematology Analyzers
- Flow Cytometers
- Coagulation Analyzers
- Slide Stainers
- Centrifuges
- Hemoglobinometers
- Others
-
- Coagulation Reagents
- Flow Cytometers Reagents
- Immuno-hematology Reagents
- Others
-
- Auto Immune Disease
- Cancer
- Diabetes Mellitus
- Infectious Disease
- Others
-
- Hospitals and Clinics
- Research Institutes
- Others
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Abbott Laboratories
- Sysmex Co.
- Beckman Coulter
- Horiba, Ltd.
- Boule Diagnostics AB
- Mind ray Medical International Limited
- Siemens Healthcare
- Roche Diagnostics
- Bio Rad laboratories
- Sigma Aldrich Co.
- Nihon Kohden Corporation
